Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Strength After Breast Cancer

for
Breast Cancer
Location: Boston MA
Sponsor: MGH Institute of Health Professions

Sex: Female

Age: 18+

Code: NCT06052488

Recruiting

Evaluation of an Algorithmically Enhanced Personalized Music-based Intervention on Stress Reduction in Cancer Patients

for
Cancer, Stress
Location: Boston MA
Sponsor: Rubato Life

Sex: All

Age: 18+

Code: NCT05519488

Recruiting

Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

for
Breast Cancer Surgery
Location: New Haven CT, Quebec, Montreal, Philadelphia PA,
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: Female

Age: 18 - 70+

Code: NCT06888388

Recruiting

Engage Psychosocial Intervention for Cancer Symptoms

for
Advanced Breast Cancer, Advanced Prostate Cancer,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06555588

Recruiting

Opioid Dispensing Device for Post-Operative Pain in Cancer Patients

for
Opioid Use, Breast Cancer
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18 - 70+

Code: NCT05585788

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer

for
Breast Cancer
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: Female

Age: 45 - 70+

Code: NCT05984888

Recruiting

Prospective Urban Rural Epidemiology Study

for
Cardiovascular Diseases, Risk Factor, Cardiovascular,
Location: Quebec City, Ottawa, Hamilton, Vancouver
Sponsor: Population Health Research Institute

Sex: All

Age: 35 - 70

Code: NCT03225586

Recruiting

Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Nashville TN
Sponsor: MetaboMed Inc

Sex: All

Age: 18+

Code: NCT04990739

Phase 1, Recruiting

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Colorectal Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Syracuse NY,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT03526835

Phase 1, Phase 2, Recruiting

Pre-pectoral Versus Sub-pectoral Implant Placement in Immediate Breast Reconstruction

for
Mastectomy, Breast Cancer
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: Female

Age: 20 - 70+

Code: NCT03959709

Recruiting

Beat Childhood Cancer Specimen Banking and Data Registry

for
Pediatric Cancer, Survivorship
Location: Hartford CT, Norfolk VA, Hershey PA, Miami FL,
Sponsor: Giselle Sholler

Sex: All

Age: 0+

Code: NCT04715178

Recruiting

Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer

for
Breast Cancer, PALB2-Mutated Breast Carcinoma,
Location: Boston MA, Rochester MN
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06488378

Phase 1, Recruiting

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer

for
Breast Cancer, DCIS, LCIS
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Female

Age: 40+

Code: NCT03936478

Phase 2, Recruiting

First In Human Study of CX-2051 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, The Bronx NY, Fairfax VA, Huntersville NC,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06265688

Phase 1, Recruiting

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

for
Metastatic Breast Cancer, Stage IV Breast Cancer, Breast Cancer,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06678269

Phase 1, Recruiting

The IMPACT Implementation-Effectiveness Trial

for
Cancer
Location: St. Catharines, Burlington, Hamilton
Sponsor: McMaster University

Sex: All

Age: 18+

Code: NCT06323707

Phase 2, Recruiting

Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04557709

Recruiting

Response to Influenza Vaccination in Pediatric Oncology Patients

for
Hematologic Malignancy, Pediatric Cancer,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 18

Code: NCT05384288

Recruiting

Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

for
Metastatic Breast Cancer
Location: Kingston, Toronto
Sponsor: Dr. Christopher Mueller

Sex: Female

Age: 18+

Code: NCT05804578

Recruiting

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

for
Neoplasms
Location: New York NY, Montreal, Toronto, Pittsburgh PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18+

Code: NCT06311578

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial